FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathryn Mason

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Procedures

Co-author Network

Publications

TOP 3
Fumihiko Matsumoto; Luka Milas; K. Kian Ang; Kathryn A Mason; David N Valdecanas; Uma Raju
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation.
Oliver Riesterer; Kathryn A Mason; Uma Raju; Qiuan Yang; Li Wang; Walter N Hittelman; K Kian Ang; Luka Milas
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Kathryn A Mason; David Valdecanas; Nancy R Hunter; Luka Milas
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathryn Mason (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Fumihiko Matsumoto; Luka Milas; K. Kian Ang; Kathryn A Mason; David N Valdecanas; Uma Raju
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation.
Anticancer research 2012;32(8):3029-35.
2009: Oliver Riesterer; Kathryn A Mason; Uma Raju; Qiuan Yang; Li Wang; Walter N Hittelman; K Kian Ang; Luka Milas
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):383-7.
2008: Kathryn A Mason; David Valdecanas; Nancy R Hunter; Luka Milas
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
Investigational new drugs 2008;26(1):1-5.
2007: Nicole Wiedenmann; Masashi Koto; Uma Raju; Luka Milas; Kathryn A Mason
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.
Investigational new drugs 2007;25(5):411-6.
2007: Kathryn A Mason; Michael T Gillin; Radhe Mohan; James D Cox
Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston.
International journal of radiation oncology, biology, physics 2007;68(4):968-70.
2007: Juliette Thariat; Gokcen Yildirim; Kathryn A Mason; Adam S Garden; Luka Milas; K. Kian Ang
Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.
International journal of clinical oncology 2007;12(2):99-110.
2007: Nicole Wiedenmann; David Valdecanas; Nancy Hunter; Stephen Hyde; Thomas Buchholz; Luka Milas; Kathryn A Mason
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1868-74.
2007: Luka Milas; Fu-Min Fang; Kathryn A Mason; David Valdecanas; Nancy Hunter; Masashi Koto; K. Kian Ang
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
International journal of radiation oncology, biology, physics 2007;67(2):568-72.
2007: Zhongxing Liao; Kathryn A Mason; Luka Milas
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
Drugs 2007;67(6):821-45.
2006: Kathryn A Mason; Robert Neal; Nancy Hunter; Hisanori Ariga; K. Kian Ang; Luka Milas
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):192-8.
2006: Uma Raju; Hisanori Ariga; Masashi Koto; Xueguan Lu; Jessica Pickett; David Valdecanas; Kathryn A Mason; Luka Milas
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):185-91.
2005: Kathryn A Mason
Radiation interactions with taxanes, old and new.
Radiation research 2005;163(6):705-6.
2005: Kathryn A Mason; Hisanori Ariga; Robert Neal; David Valdecanas; Nancy Hunter; Arthur M Krieg; John K Whisnant; Luka Milas
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):361-9.
2004: Radhika Iyer; Howard D Thames; Ja Rhonda Tealer; Kathryn A Mason; Susan C Evans
Effect of reduced EGFR function on the radiosensitivity and proliferative capacity of mouse jejunal crypt clonogens.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):283-9.
2004: Luka Milas; Kathryn A Mason; Hisanori Ariga; Nancy Hunter; Robert Neal; David Valdecanas; Arthur M Krieg; John K Whisnant
CpG oligodeoxynucleotide enhances tumor response to radiation.
Cancer research 2004;64(15):5074-7.
2004: Kathryn A Mason; Nancy Hunter; Uma Raju; Hisanori Ariga; Amir Husain; David Valdecanas; Robert Neal; K. Kian Ang; Luka Milas
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
International journal of radiation oncology, biology, physics 2004;59(4):1181-9.
2004: Nicolaus Andratschke; Klaus Dittmann; Kathryn A Mason; Zhen Fan; Zhongxing Liao; Ritsuko Komaki; K. Kian Ang; Luka Milas
Epidermal growth factor receptor as a target to improve treatment of lung cancer.
Clinical lung cancer 2004;5(6):340-52.
2004: William A Brock; Luka Milas; Sherry Bergh; Ruth Lo; Csaba Szabó; Kathryn A Mason
Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Cancer letters 2004;205(2):155-60.
2004: Eiko Nakata; Kathryn A Mason; Nancy Hunter; Amir Husain; Uma Raju; Zhongxing Liao; K. Kian Ang; Luka Milas
Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
International journal of radiation oncology, biology, physics 2004;58(2):369-75.
2003: L Milas; Kathryn A Mason; K. Kian Ang
Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings.
International journal of radiation biology 2003;79(7):539-45.
2003: Uma Raju; Eiko Nakata; Kathryn A Mason; K. Kian Ang; Luka Milas
Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Cancer research 2003;63(12):3263-7.
2003: Zhongxing Liao; Ritsuko Komaki; Kathryn A Mason; Luka Milas
Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.
Clinical lung cancer 2003;4(6):356-65.
2003: Luka Milas; Kathryn A Mason; Christopher H Crane; Zhongxing Liao; Jaime Masferrer
Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):15-24.
2003: Luka Milas; Kathryn A Mason; Nancy Hunter; Chun Li; Sidney Wallace
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
International journal of radiation oncology, biology, physics 2003;55(3):707-12.
2003: Luka Milas; Kathryn A Mason; Zhongxing Liao; K. Kian Ang
Chemoradiotherapy: emerging treatment improvement strategies.
Head & neck 2003;25(2):152-67.
2002: Luka Milas; Tetsuo Akimoto; Nancy Hunter; Kathryn A Mason; Lara Buchmiller; Michitaka Yamakawa; Hiroyuki Muramatsu; K. Kian Ang
Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.
International journal of radiation oncology, biology, physics 2002;52(2):514-21.
2001: Kathryn A Mason; Ritsuko Komaki; James D Cox; Luka Milas
Biology-based combined-modality radiotherapy: workshop report.
International journal of radiation oncology, biology, physics 2001;50(4):1079-89.
2001: Susan C Evans; D C Mack; Kathryn A Mason; Howard D Thames
The proliferative response of mouse jejunal crypt cells to radiation-induced cell depletion is not mediated exclusively by transforming growth factor alpha.
Radiation research 2001;155(6):866-9.
2001: Michael M Weil; C Xia; X Xia; Xiangjun Gu; Christopher I Amos; Kathryn A Mason
A chromosome 15 quantitative trait locus controls levels of radiation-induced jejunal crypt cell apoptosis in mice.
Genomics 2001;72(1):73-7.
2001: T P Phan; Christopher H Crane; Nora Janjan; E Vrdoljak; Luka Milas; Kathryn A Mason
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(1):19-23.
2000: Alexander Kirichenko; Kathryn A Mason; Martin Straume; C David Teates; tyvin rich
Nuclear scintigraphic assessment of radiation-induced intestinal dysfunction.
Radiation research 2000;153(2):164-72.
1999: Kathryn A Mason; Kazushi Kishi; Nancy Hunter; Lara Buchmiller; Tetsuo Akimoto; Ritsuko Komaki; Luka Milas
Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4191-8.
1999: Kathryn A Mason; Luka Milas; Nancy Hunter; Mohamed A Elshaikh; Lara Buchmiller; Kazushi Kishi; K Hittelman; K. Kian Ang
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
International journal of radiation oncology, biology, physics 1999;44(5):1125-35.
1999: Ronald Schimming; N R Hunter; Kathryn A Mason; L Milas
[Inhibition of tumor neo-angiogenesis and induction of apoptosis as properties of docetaxel (taxotere)].
Mund-, Kiefer- und Gesichtschirurgie : MKG 1999;3(4):210-2.
1999: Luka Milas; MM Milas; Kathryn A Mason
Combination of taxanes with radiation: preclinical studies.
Seminars in radiation oncology 1999;9(2 Suppl 1):12-26.
1999: Ronald Schimming; Kathryn A Mason; N Hunter; M Weil; Kazushi Kishi; L Milas
Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel.
Cancer chemotherapy and pharmacology 1999;43(2):165-72.
1998: Arnout C Ruifrok; Michael M Weil; Kathryn A Mason; Howard D Thames
Induction of transforming growth factor alpha in irradiated mouse jejunum.
International journal of radiation oncology, biology, physics 1998;42(5):1137-46.
1998: Arnout C Ruifrok; Michael M Weil; Howard D Thames; Kathryn A Mason
Diurnal variations in the expression of radiation-induced apoptosis.
Radiation research 1998;149(4):360-5.
1997: Kathryn A Mason; Nancy Hunter; MM Milas; James L Abbruzzese; Luka Milas
Docetaxel enhances tumor radioresponse in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2431-8.
1997: CG Milross; Kathryn A Mason; Nancy Hunter; N H Terry; N Patel; S Harada; T Jibu; J Seong; Luka Milas
Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1299-308.
1997: Howard D Thames; Arnout C Ruifrok; Kathryn A Mason
The effect of proliferative status and clonogen content on the response of mouse jejunal crypts to split-dose irradiation.
Radiation research 1997;147(2):172-8.
1997: CG Milross; Susan L Tucker; Kathryn A Mason; Nancy Hunter; L J Peters; Luka Milas
The effect of tumor size on necrosis and polarographically measured pO2.
Acta oncologica (Stockholm, Sweden) 1997;36(2):183-9.
1997: Arnout C Ruifrok; Kathryn A Mason; Guillermina Lozano; Howard D Thames
Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment.
Radiation research 1997;147(1):1-12.
1996: Michael M Weil; Christopher I Amos; Kathryn A Mason; L Clifton Stephens
Genetic basis of strain variation in levels of radiation-induced apoptosis of thymocytes.
Radiation research 1996;146(6):646-51.
1996: Michael M Weil; L Clifton Stephens; Christopher I Amos; Arnout C Ruifrok; Kathryn A Mason
Strain difference in jejunal crypt cell susceptibility to radiation-induced apoptosis.
International journal of radiation biology 1996;70(5):579-85.
1996: Ritsuko Komaki; T Fujii; P Perkins; Jae Y Ro; Pamela K Allen; Kathryn A Mason; C F Mountain; Luka Milas
Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.
International journal of radiation oncology, biology, physics 1996;36(3):601-5.
1996: CG Milross; Kathryn A Mason; Nancy Hunter; W K Chung; LJ Peters; Luka Milas
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Journal of the National Cancer Institute 1996;88(18):1308-14.
1996: Luka Milas; Y Saito; Nancy Hunter; CG Milross; Kathryn A Mason
Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):163-70.
1996: Howard D Thames; Arnout C Ruifrok; Luka Milas; Nancy Hunter; Kathryn A Mason; Nicholas H A Terry; R A White
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
International journal of radiation oncology, biology, physics 1996;35(5):951-62.
1996: Arnout C Ruifrok; Kathryn A Mason; Howard D Thames
Changes in clonogen number and radiation sensitivity in mouse jejunal crypts after treatment with dimethylsulfoxide and retinoic acid.
Radiation research 1996;145(6):740-5.
1996: Raymond E Meyn; L Clifton Stephens; Kathryn A Mason; D Medina
Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: significance of gland differentiation and p53 status.
International journal of cancer. Journal international du cancer 1996;65(4):466-72.
1996: Luka Milas; CG Milross; Kathryn A Mason
Cytotoxic treatments and tumor oxygenation.
The cancer journal from Scientific American 1996;2(1):59-60; author reply 60-1.
1995: CG Milross; LJ Peters; Nancy Hunter; Kathryn A Mason; Luka Milas
Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo.
International journal of cancer. Journal international du cancer 1995;62(5):599-604.
1995: Luka Milas; Nancy Hunter; Kathryn A Mason; CG Milross; Y Saito; LJ Peters
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Cancer research 1995;55(16):3564-8.
1995: Kathryn A Mason; Luka Milas; LJ Peters
Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
International journal of radiation oncology, biology, physics 1995;32(5):1381-9.
1995: Luka Milas; Nancy Hunter; B Kurdoglu; Kathryn A Mason; Raymond E Meyn; L Clifton Stephens; LJ Peters
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.
Cancer chemotherapy and pharmacology 1995;35(4):297-303.
1995: Luka Milas; Nancy Hunter; Kathryn A Mason; CG Milross; LJ Peters
Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse.
Acta oncologica (Stockholm, Sweden) 1995;34(3):409-12.
1994: Arnout C Ruifrok; Kathryn A Mason; Nancy Hunter; Howard D Thames
Changes in the radiation sensitivity of mouse skin during fractionated and prolonged treatments.
Radiation research 1994;139(3):334-43.
1994: Luka Milas; Nancy Hunter; Kathryn A Mason; B Kurdoglu; LJ Peters
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Cancer research 1994;54(13):3506-10.
1994: Kathryn A Mason; Howard D Thames; T G Ochran; Arnout C Ruifrok; Nora Janjan
Comparison of continuous and pulsed low dose rate brachytherapy: biological equivalence in vivo.
International journal of radiation oncology, biology, physics 1994;28(3):667-71.
1994: Kathryn A Mason; Philip J Tofilon
Unexpected radiation protection with 13-cis-retinoic acid plus interferon alpha-2a.
Cancer chemotherapy and pharmacology 1994;33(5):435-7.
1993: Kathryn A Mason; S Murphy; Luka Milas
Stimulation of hematopoietic cell recovery by tetrachlorodecaoxide in sublethally irradiated mice.
Radiation research 1993;136(2):229-35.
1993: Kathryn A Mason; H Rodney Withers; C S Chiang
Late effects of radiation on the lumbar spinal cord of guinea pigs: re-treatment tolerance.
International journal of radiation oncology, biology, physics 1993;26(4):643-8.
1993: H Rodney Withers; Kathryn A Mason; Jeremy Taylor; D K Kim; James B Smathers
Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
Radiation research 1993;134(3):295-300.
1993: H Rodney Withers; Kathryn A Mason; Jeremy Taylor
The number of clonogenic cells in a mouse jejunal crypt.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;26(3):238-43.
1992: C S Chiang; Kathryn A Mason; H Rodney Withers; william mcbride
Alteration in myelin-associated proteins following spinal cord irradiation in guinea pigs.
International journal of radiation oncology, biology, physics 1992;24(5):929-37.
1991: Jeremy Taylor; H Rodney Withers; Kathryn A Mason; C A Davis
Repopulation of mouse jejunal crypt cells.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20(3):181-90.
1991: Susan L Tucker; Howard D Thames; B W Brown; Kathryn A Mason; Nancy Hunter; H Rodney Withers
Direct analyses of in vivo colony survival after single and fractionated doses of radiation.
International journal of radiation biology 1991;59(3):777-95.
1991: R E Meyn; LJ Peters; M D Mills; M F Moyers; R S Fields; H Rodney Withers; Kathryn A Mason
Radiobiological aspects of electron beams.
Frontiers of radiation therapy and oncology 1991;25():53-60.
1989: william mcbride; Kathryn A Mason; C Davis; H Rodney Withers; James B Smathers
Adhesion formation in experimental chronic radiation enteropathy.
International journal of radiation oncology, biology, physics 1989;16(3):737-43.
1989: Kathryn A Mason; H Rodney Withers; william mcbride; C A Davis; James B Smathers
Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation.
Radiation research 1989;117(3):480-8.
1989: Kathryn A Mason; H Rodney Withers; C A Davis
Dose dependent latency of fatal gastrointestinal and bone marrow syndromes.
International journal of radiation biology 1989;55(1):1-5.
1987: Kathryn A Mason; J T Wu; H Rodney Withers; L J Peters
Palliative radiotherapy of a mouse mammary carcinoma.
International journal of radiation oncology, biology, physics 1987;13(12):1875-82.